Your browser is no longer supported. Please, upgrade your browser.
Settings
BCR C. R. Bard, Inc. daily Stock Chart
BCR [NYSE]
C. R. Bard, Inc.
IndexS&P 500 P/E43.76 EPS (ttm)7.59 Insider Own0.20% Shs Outstand72.91M Perf Week-0.15%
Market Cap24.21B Forward P/E25.40 EPS next Y13.07 Insider Trans-59.62% Shs Float72.63M Perf Month-0.96%
Income568.60M PEG3.71 EPS next Q3.08 Inst Own82.00% Short Float1.45% Perf Quarter2.83%
Sales3.88B P/S6.25 EPS this Y297.20% Inst Trans0.05% Short Ratio2.12 Perf Half Y5.73%
Book/sh27.49 P/B12.08 EPS next Y9.94% ROA10.60% Target Price315.40 Perf Year53.28%
Cash/sh15.88 P/C20.91 EPS next 5Y11.79% ROE31.50% 52W Range216.54 - 337.73 Perf YTD47.81%
Dividend1.04 P/FCF38.32 EPS past 5Y13.80% ROI17.30% 52W High-1.68% Beta0.54
Dividend %0.31% Quick Ratio1.40 Sales past 5Y5.10% Gross Margin62.80% 52W Low53.34% ATR2.19
Employees16300 Current Ratio1.70 Sales Q/Q5.10% Oper. Margin19.20% RSI (14)48.69 Volatility0.44% 0.57%
OptionableYes Debt/Eq0.81 EPS Q/Q-2.20% Profit Margin14.70% Rel Volume0.88 Prev Close332.06
ShortableYes LT Debt/Eq0.57 EarningsJan 24 AMC Payout13.40% Avg Volume495.99K Price332.06
Recom3.00 SMA20-0.63% SMA500.70% SMA2008.31% Volume0 Change0.00%
Apr-25-17Downgrade Raymond James Strong Buy → Mkt Perform
Jan-05-17Upgrade Raymond James Outperform → Strong Buy $265
Jan-03-17Upgrade Morgan Stanley Equal-Weight → Overweight $240 → $260
Sep-16-16Upgrade Wells Fargo Market Perform → Outperform
Jul-27-16Reiterated Deutsche Bank Hold $234 → $240
Jul-27-16Reiterated Barclays Equal Weight $224 → $235
Jul-08-16Downgrade BofA/Merrill Buy → Neutral
May-24-16Reiterated Barclays Equal Weight $212 → $224
Apr-28-16Reiterated Barclays Equal Weight $195 → $212
Mar-17-16Initiated Nomura Neutral
Nov-12-15Initiated Citigroup Buy
Aug-27-15Upgrade Goldman Neutral → Buy
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Dec-08-17 11:15AM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : December 08th, 2017 (record date) : By the numbers : December 8, 2017 Capital Cube
Dec-07-17 01:01PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : December 7, 2017 Capital Cube
Dec-03-17 12:50PM  How Does C R Bard Incs (BCR) EPS Growth Stack Up Against Industry Performance? Simply Wall St.
Nov-30-17 07:35AM  What Jabil's new director signals about the company's future American City Business Journals
Nov-29-17 07:50AM  Market Trends Toward New Normal in Cloudera, C.R. Bard, Jabil Circuit, Valero Energy, Navient, and Interpace Diagnostics Group Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-27-17 12:15PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 27, 2017 Capital Cube
06:04AM  3 Top Diabetes Stocks to Buy Now Motley Fool
Nov-25-17 03:32PM  Paul Tudor Jones: The Global Macro Trader GuruFocus.com
Nov-16-17 06:36AM  BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines PR Newswire
Nov-14-17 08:02AM  See what the IHS Markit Score report has to say about C R Bard Inc. Markit
Nov-13-17 11:50AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 13, 2017 Capital Cube
07:40AM  Earnings Review and Free Research Report: C.R. Bards Revenue Grew 5%; Adjusted EPS Increased 14.3% ACCESSWIRE
Nov-06-17 07:10AM  Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board ACCESSWIRE
Nov-01-17 11:53AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 1, 2017 Capital Cube
Oct-30-17 10:15AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017 Capital Cube
Oct-25-17 05:05PM  C.R. Bard beats 3Q profit forecasts Associated Press
04:15PM  Bard Announces Third Quarter Results Business Wire
Oct-23-17 11:08AM  Research Report Identifies Sherwin-Williams, Charter Communications, Biogen, C. R. Bard, Mohawk Industries, and Humana Inc. with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
09:44AM  EW vs. BCR: Which Stock is Poised for Better Q3 Earnings? Zacks
Oct-18-17 10:17AM  BD Statement On European Commission Conditional Clearance Of Bard Acquisition PR Newswire
Oct-17-17 08:27AM  Can CR Bard (BCR) Spring a Surprise This Earnings Season? Zacks
Oct-16-17 11:06AM  EU mergers and takeovers (Oct 16) Reuters
Oct-11-17 04:15PM  Bard Declares Quarterly Dividend Business Wire
Sep-18-17 10:35AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : BCR-US : September 18, 2017 Capital Cube
Sep-15-17 12:35PM  BD Stock Fell 2.7% on September 13: Should Investors Worry? Market Realist
Sep-12-17 09:42AM  Becton, Dickinson's (BCR) C.R. Bard Buyout Plans Bode Well Zacks
Sep-05-17 10:48PM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : September 6, 2017 Capital Cube
Sep-01-17 10:13AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : September 1, 2017 Capital Cube
Aug-29-17 09:06AM  C. R. Bard's (BCR) LUTONIX 035 Gets FDA Pre-Market Approval Zacks
Aug-28-17 11:36AM  Becton Dickinsons Bard Acquisition: On Track, Gaining Momentum Market Realist
09:00AM  C. R. Bard Receives FDA Premarket Approval of the LUTONIX® 035 Drug Coated Balloon as the First and Only DCB for the Treatment of Patients with Dysfunctional AV Fistulae Business Wire
Aug-25-17 01:56PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : July 24th, 2017 (record date) : By the numbers : August 25, 2017 Capital Cube
Aug-21-17 09:05AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : BCR-US : August 21, 2017 Capital Cube
Aug-15-17 03:31PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 15, 2017 Capital Cube
Aug-09-17 07:27AM  C.R. Bard Shareholders Approve Merger With Becton, Dickinson Zacks
Aug-08-17 04:54PM  Bard Shareholders Approve Proposed Merger With Becton, Dickinson PR Newswire
Aug-01-17 12:31PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017 Capital Cube
Jul-31-17 07:40AM  Featured Company News - Haemonetics Announces FDA Clearance for its NexSys PCS; Set to Reduce Cost per Liter of Plasma Collected ACCESSWIRE
Jul-28-17 09:52AM  C.R. Bard (BCR) Beats Earnings & Revenue Estimates in Q2 Zacks
Jul-27-17 09:54PM  C.R. Bard tops Street 2Q forecasts Associated Press
04:15PM  Bard Announces Second Quarter Results Business Wire
Jul-20-17 08:53AM  Is a Surprise in Store for CR Bard (BCR) in Q2 Earnings? Zacks
Jul-10-17 09:03AM  Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition Zacks
Jun-22-17 08:00PM  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against C. R. Bard, Inc. GlobeNewswire
Jun-14-17 04:15PM  Bard Declares Quarterly Dividend Business Wire
03:48PM  Seven iQ100 members hit all-time highs CNBC Videos
Jun-09-17 05:15PM  BD and Bard Receive Second Requests from FTC under HSR Act PR Newswire
03:49PM  Four members of iQ100 hitting all-time highs CNBC Videos
Jun-01-17 03:14PM  Nine members of iQ100 hit all time highs CNBC Videos
May-31-17 03:48PM  Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals
01:59PM  Seven iQ 100 members hit all-time highs CNBC Videos
12:22PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 31, 2017 Capital Cube
May-23-17 09:58AM  C.R. Bard (BCR) Up 1.6% Since Earnings Report: Can It Continue? Zacks
09:20AM  Becton, Dickinson and Company -- Moody's assigns Baa2 to Becton Dickinson's new euro senior unsecured notes; rating on review for downgrade Moody's
May-22-17 10:32AM  Becton, Dickinson and Company -- Moody's assigns Ba1 to Becton Dickinson's senior unsecured notes related to Bard Moody's
May-15-17 06:48PM  Lifshitz & Miller LLP Announces Investigation of C. R. Bard, Inc., HCSB Financial Corp., Home Capital Group Inc., Paragon Commercial Corporation, PCM, Inc., Pingtan Marine Enterprise Ltd. and United States Steel Corporation PR Newswire
03:21PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 15, 2017 Capital Cube
09:13AM  CR Bard (BCR) Hits a 52-Week High: What's Driving the Stock? Zacks
May-09-17 06:18PM  Becton, Dickinson and Company -- Moody's Assigns Ba1 to Becton Dickinson's Exchange Notes Moody's
May-02-17 03:44PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 2, 2017 Capital Cube
12:11PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR Business Wire
May-01-17 10:39AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 Capital Cube
Apr-30-17 06:00AM  INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Shareholders To Contact The Firm For Additional Information Business Wire
Apr-28-17 12:40PM  Five CNBC IQ 100 components are hitting lifetime highs CNBC Videos
Apr-27-17 04:39PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR PR Newswire
01:35PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : May 01st, 2017 (record date) : By the numbers : April 27, 2017 Capital Cube
09:07AM  How BD-Bard Acquisition Will Strengthen International Presence Market Realist
09:04AM  3 Best Performing Stocks of April Motley Fool
07:37AM  How the BD-Bard Deal Will Create Shareholder Value Market Realist
Apr-26-17 05:41PM  SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
01:35PM  C.R. Bards Business Profile and the BD-Bard Deal Rationale Market Realist
12:05PM  A Look at BDs Deal Rationale in Its C.R. Bard Acquisition Market Realist
11:13AM  Which Companies Are Now Outperforming 95% Of All Stocks? Investor's Business Daily
11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
10:30AM  BD to Acquire C.R. Bard: Deal Highlights and Market Reaction Market Realist
Apr-25-17 01:10PM  C. R. Bard Stock Trades Ex-Dividend Thursday Investopedia
12:54PM  WeissLaw LLP: The C. R. Bard, Inc. and Becton, Dickson and Company Merger May Not Be in the Best Interests of BCR Unitholders PR Newswire
09:41AM  C.R. BARD INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of C.R. Bard, Inc. PR Newswire
09:03AM  Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More TheStreet.com
08:15AM  Blog Coverage Becton, Dickinson and C. R. Bard Set to Merge in a $24 Billion Deal Accesswire
12:36AM  [$$] Dont Succumb to Sticker Shock on Becton Dickinson Deal The Wall Street Journal
Apr-24-17 06:44PM  Tax cuts not driving this rally CNBC Videos +19.50%
06:37PM  Cramer: Trump tax cuts are not the driving force behind t... CNBC Videos
06:11PM  Cramer: Trump tax cuts are not the driving force behind this rally CNBC
06:01PM  Why C.R. Bard Shares Skyrocketed 19.5% Today Motley Fool
04:42PM  Endless Loop: Becton Dickinson Drops 4.4% on C.R. Bard Acquisition Barrons.com
04:32PM  Why C.R. Bard, Deutsche Bank, and Sonic Jumped Today Motley Fool
04:29PM  Becton Dickinson To Buy Medical Tech Firm C.R. Bard For $24 Billion Investor's Business Daily
04:28PM  Endless Loop: C.R. Bard Soars 20% on Becton Dickinson Acquisition Barrons.com
04:07PM  Harwood Feffer LLP Announces Investigation of C. R. Bard, Inc. PR Newswire
01:19PM  [$$] Don't Succumb to Sticker Shock on Becton Dickinson Deal The Wall Street Journal
12:09PM  C.R. BARD, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
12:04PM  C. R. Bard, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with Becton, Dickinson and Co. Business Wire
12:03PM  Story Stocks from Briefing.com Briefing.com
10:54AM  Global Markets Surge On French Runoff Election Vote And Heavy Deal News Forbes
10:43AM  Jim Cramer on Becton Dickinson's Purchase of Bard TheStreet.com
10:26AM  Behind the $24 billion medical device deal CNBC Videos
10:24AM  Stock Market News for April 24, 2017 Zacks
10:18AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR Accesswire
09:19AM  A $24 Billion Megadeal to Cheer About Bloomberg
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEILAND JOHN HVice Chairman, Pres. and COONov 07Option Exercise136.3733,4354,559,53176,331Nov 09 02:16 PM
WEILAND JOHN HVice Chairman, Pres. and COONov 07Sale333.3133,43511,144,20342,896Nov 09 02:16 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFONov 02Option Exercise115.7238,2424,425,50165,233Nov 06 06:45 PM
Lupisella Frank JrVice President and ControllerNov 02Option Exercise153.336,5771,008,43316,746Nov 06 06:45 PM
Lupisella Frank JrVice President and ControllerNov 02Sale334.707,0352,354,5829,711Nov 06 06:45 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFONov 02Sale334.0438,24212,774,27726,991Nov 06 06:45 PM
Barrett David MDirectorOct 30Sale327.313,3441,094,5291,612Oct 31 04:46 PM
Larson Betty DVP - Human ResourcesOct 20Option Exercise166.675,906984,36214,305Oct 24 09:50 AM
Larson Betty DVP - Human ResourcesOct 20Sale330.165,9061,949,9258,399Oct 24 09:50 AM
Lupisella Frank JrVice President and ControllerOct 18Option Exercise92.749,173850,66519,342Oct 20 10:14 AM
Lupisella Frank JrVice President and ControllerOct 18Sale325.009,1732,981,22710,169Oct 20 10:14 AM
Collins Timothy PGroup PresidentOct 12Option Exercise128.9755,8187,198,84182,464Oct 16 07:01 PM
Collins Timothy PGroup PresidentOct 12Sale322.0355,81817,974,88626,646Oct 16 07:01 PM
Collins Timothy PGroup PresidentOct 09Option Exercise84.5861451,92927,260Oct 10 11:37 AM
Collins Timothy PGroup PresidentOct 09Sale322.00614197,70826,646Oct 10 11:37 AM
Collins Timothy PGroup PresidentOct 06Option Exercise84.587,774657,48634,420Oct 10 11:37 AM
Collins Timothy PGroup PresidentOct 06Sale322.007,7742,503,22826,646Oct 10 11:37 AM
Luboff Sharon MGroup Vice PresidentSep 29Option Exercise85.2530,2522,578,87951,076Oct 02 02:37 PM
Luboff Sharon MGroup Vice PresidentSep 29Sale320.0030,2529,680,64020,824Oct 02 02:37 PM
Groetelaars John PGroup PresidentAug 10Option Exercise116.6323,6872,762,68442,650Aug 11 12:19 PM
Groetelaars John PGroup PresidentAug 10Sale318.7323,6877,549,83318,963Aug 11 12:19 PM
WELTERS ANTHONYDirectorMay 30Option Exercise85.232,400204,5404,884Jun 01 12:40 PM
WELTERS ANTHONYDirectorMay 24Option Exercise83.471,200100,1682,809May 26 10:30 AM
Thompson Tommy GDirectorMay 23Option Exercise83.4770058,4317,704May 25 11:14 AM
WHITE TONY LDirectorMay 16Option Exercise83.471,200100,16815,213May 18 11:06 AM
Lupisella Frank JrVice President and ControllerApr 24Sale304.003,6221,101,08810,139Apr 25 05:24 PM
Beasley Jim CGroup PresidentFeb 21Option Exercise186.434,390818,40626,625Feb 22 03:37 PM
Beasley Jim CGroup PresidentFeb 21Sale245.004,3901,075,55022,235Feb 22 03:37 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 14Sale240.4914,0913,388,80942,896Feb 15 04:58 PM
Groetelaars John PGroup PresidentFeb 14Sale240.49732176,04018,963Feb 15 04:58 PM
Collins Timothy PGroup PresidentFeb 14Sale240.503,768906,18626,646Feb 15 04:58 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 14Sale240.512,788670,55219,530Feb 15 04:58 PM
Beasley Jim CGroup PresidentFeb 14Sale240.523,213772,79622,235Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 14Sale240.533,659880,09520,718Feb 15 04:58 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 14Sale240.53618148,64626,922Feb 15 04:58 PM
RING TIMOTHY MChairman and CEOFeb 14Sale240.5014,4253,469,16973,965Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 13Option Exercise86.151,00086,14528,813Feb 14 03:21 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 13Sale240.001,274305,75868,759Feb 14 03:20 PM
Collins Timothy PGroup PresidentFeb 13Sale240.30642154,27333,873Feb 14 03:20 PM
RING TIMOTHY MChairman and CEOFeb 13Sale240.021,767424,118102,139Feb 14 03:20 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 13Sale240.09642154,13628,140Feb 14 03:20 PM
Groetelaars John PGroup PresidentFeb 13Sale240.04450108,01820,362Feb 14 03:20 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 13Sale240.07469112,59424,662Feb 14 03:20 PM
Beasley Jim CGroup PresidentFeb 13Sale240.10734176,23027,652Feb 14 03:21 PM
Luboff Sharon MGroup Vice PresidentFeb 13Sale240.241,478355,08127,335Feb 14 03:21 PM
Larson Betty DVP - Human ResourcesFeb 10Sale240.923,292793,1108,399Feb 13 03:11 PM
Beasley Jim CGroup PresidentFeb 09Sale239.588,5932,058,67428,917Feb 10 06:23 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 09Sale239.577,5971,819,98029,405Feb 10 06:23 PM
RING TIMOTHY MChairman and CEOFeb 09Sale239.5620,3244,868,880105,618Feb 10 06:23 PM
Luboff Sharon MGroup Vice PresidentFeb 09Sale239.595,8011,389,87428,221Feb 10 06:23 PM
Collins Timothy PGroup PresidentFeb 09Sale238.987,6021,816,73835,138Feb 10 06:23 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 09Sale239.585,8161,393,38725,548Feb 10 06:23 PM
Groetelaars John PGroup PresidentFeb 09Sale239.665,5041,319,08621,248Feb 10 06:23 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Feb 09Sale239.605,8271,396,12916,332Feb 10 06:23 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 09Sale239.5414,2813,420,93271,131Feb 10 06:23 PM
Naughton Gail KDirectorJan 31Sale236.2236786,6941,620Feb 01 09:31 AM
Groetelaars John PGroup PresidentJan 11Sale235.00573134,65516,554Jan 12 12:05 PM
Lupisella Frank JrVice President and ControllerJan 10Sale232.002,735634,52011,603Jan 11 04:14 PM
Lupisella Frank JrVice President and ControllerJan 09Sale232.0021048,72014,338Jan 11 04:14 PM
Beasley Jim CGroup PresidentDec 30Option Exercise168.874,709795,18527,378Jan 03 02:52 PM
Lupisella Frank JrVice President and ControllerDec 30Sale226.0023753,56214,520Jan 03 02:52 PM
Beasley Jim CGroup PresidentDec 30Sale225.004,7091,059,52522,669Jan 03 02:52 PM